Which Japanese patients with type 1 diabetes would benefit from continuous subcutaneous insulin infusion?

Which Japanese patients with type 1 diabetes would benefit from continuous subcutaneous insulin infusion? - Which Japanese patients with type 1 diabetes would benefit from continuous subcutaneous insulin infusion?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018263

Enrollment

Registered

2015-07-09

Start date

2005-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocrinology and Metabolism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 1 diabetic patients provided written informed consent to participate in the study,and treated with CSII

Exclusion criteria

Exclusion criteria: severe visual impairment, hearing disturbance, and those who could not perform self-monitoring of blood glucose at least four times per day.

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Countries

Japan

Contacts

Public ContactKentaro Taki

The Jikei university school of medicine Diabetes,metabolism and endocrinology

tackey@jikei.ac.jp03-3433-1111

Outcome results